Programme

Programme Highlights
  • Advances In Radiotherapy | How Many Brain Lesions Can We Now SRS?
  • Novel Agents In Radiation Biology | Bioreductives And DNA Repair Inhibitors To Improve Radiotherapy Response In Breast Cancer
  • Contemporary Role Of Axillary Surgery Post Sentinel-Node Biopsy In Breast Cancer
  • Crossing The Blood-Brain Barrier : Systemic Therapies In Breast Cancer With Brain And Leptomeningeal Metastases
  • Utility Of PET-CT In Clinical Oncology And Cancer Research
  • Systemic Management Of Metastatic Soft Tissue Sarcoma And Novel Agents
  • Novel Promising Agents For Nasopharyngeal Carcinoma And Potential Biomarkers
  • How Artificial Intelligence Changes Medical Imaging Diagnostic?
  • Systemic Management Of Metastatic Radioiodine Refractory Differentiated Thyroid Cancers
  • Local Recurrence : Experience In Reirradiation And Brachytherapy
  • ImmunoOncology In Head & Neck Cancers
  • Precision Medicine : From Molecules To Optimizing Treatment In Clinical Practice
  • Molecular Profiling For Rare Cancers
  • Designing Phase I Clinical Trials And How It Benefits Patients
  • Treatment For Mrcc : Where Do We Fit Immunotherapy In Between Emerging Targeted Therapies?
  • Systemic Treatment For Ureteric And Bladder Cancers : From Chemotherapy To Immunotherapy
  • Clearing The Air For Systemic Treatment Sequence In Metastatic Hormone Sensitive And Hormone Refractory Prostate Cancer
  • Management Of Acute Oncology Emergencies

Comments are closed